← Back to all stories
FDA Approves Breakthrough Pill That Doubles Survival Time for Advanced Pancreatic Cancer Patients
Photo: Jiří Suchý / Unsplash
A new twice-daily pill has received immediate FDA approval after clinical trials showed it doubles the lifespan of late-stage pancreatic cancer patients, even when traditional chemotherapy has failed. This breakthrough offers a vital new lifeline and renewed hope for those facing one of the most challenging cancer diagnoses.
A new twice-daily pill has received immediate FDA approval after clinical trials showed it doubles the lifespan of late-stage pancreatic cancer patients, even when traditional chemotherapy has failed. This breakthrough offers a vital new lifeline and renewed hope for those facing one of the most challenging cancer diagnoses.